The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel

References

• International Pain Summit of the International Association for the Study of Pain. Declaration of Montreal. Declaration that access to pain management is a fundamental human right. J Pain Palliat Care Pharmacother 2011;25:29-31
   PubMedGoogle Scholar
• International Association for the Study of Pain (IASP). Available at: www.iasp-pain.org
   Google Scholar
• The European Pain Federation (EFIC). Available at: www.europeanpainfederation.eu
   Google Scholar
• Cousins MJ, Lynch ME. The Declaration Montreal: access to pain management is a fundamental human right. Pain 2011;152:2673-4
   PubMed Web of Science ®Google Scholar
• Single Convention on Narcotic Drugs, 1961. As attended by the 1972 Protocol amending the Single Convention on Narcotic Drugs, 1962. New York (NY): United Nations, 1977. Available at: http://www.unodc.org/pdf/convention_1961_en.pdf [Last accessed 18 September 2016]
   Google Scholar
• Commission on Narcotic Drugs, Discussion Paper, Ensuring availability of controlled medications for the relief of pain and preventing diversion and abuse. Striking the right balance to achieve the optimal public health outcome. E/CN.7/2011/CRP.3, March 17, 2011, para. 37. Available at: http://www.unodc.org/documents/commissions/CND/CND_V1181366_E.pdf [Last accessed 18 September 2016]
   Google Scholar
• Milani B, Scholten W. Access to Controlled Medicines. In: The World Medicines Situation 2011, 3rd edn. Geneva: World Health Organization, 2011 (Chapter released April 2011). Available at: http//www.who.int/entity/medicines/areas/policy/world_medicines_situation/WMS_ch19_wAccess.pdf [Last accessed 18 September 2016]
   Google Scholar
• Berterame S, Erthal J, Thomas J, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet 2016;387:1644-56
   PubMed Web of Science ®Google Scholar
• Garcia JB. Change Pain Latin America Advisory Panel. Change Pain Latin America – new initiative established to enhance management of patients with chronic pain in Latin America. Braz J Anesthisiol 2014;64:140-2
   PubMedGoogle Scholar
• Rico MA, Campos Kraychete D, Jreigelskandar A, et al. Use of opioids in Latin America: the need of an evidence-based change. Pain Med 2016;17:704-16
   PubMed Web of Science ®Google Scholar
• INCB, 2006 International Narcotics Control Board 2005. Report of the International Narcotics Control Board for 2005 (E/INCB/2005/1). New York: United Nations, 2006. Available at: www.ntakd.it/en/files/INCB2005(en).pdf [Last accessed 18 September 2016]
   Google Scholar
• Hernández JJ, Moreno C. Dolor el quinto signo vital. (Pain the fifth vital sign). In: Hernández JJ, Moreno C, eds. Medicina del dolor, 2nd edn. Bogotá: Ediciones Rosaristas, 2011:19-40
   Google Scholar
• Gupta A, Weber N, Duwell M. Implementing a public health approach for the management of chronic pain in the USA. Pain Manag 2013;3:315-19
   PubMedGoogle Scholar
• Gillen C, Haurand M, Kobelt DJ, et al. Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor. Naunyn Schmiedebergs Arch Pharmacol 2000;36:116-21
   Web of Science ®Google Scholar
• Vazzana M, Andreani T, Fangueiro J, et al. Tramadol hydrocloride: pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems. Biomed Pharmacother 2015;70:234-8
   PubMed Web of Science ®Google Scholar
• Raffa RB. Drugs with mixed action and combinations: emphasis on tramadol. In: Gebhart GF, Schmidt RF, eds. Encyclopaedia of Pain. Berlin, Heidelberg: Springer, 2013:1071-5
   Google Scholar
• Collart L, Luthy C, Favarlo Constantin C, et al. Dual analgesic effect of tramadol in man. Scweiz Med Wochenschr 1993;123:2241-3
   PubMedGoogle Scholar
• Grond S, Meuser T, Zech D, et al. Analgesic efficacy and safety of tramadol enantiomers in comparison with the racemate: a randomized, double-blind study with gynaecological patients using intravenous patient controlled analgesia. Pain 1995;62:313-20
   PubMed Web of Science ®Google Scholar
• Benzon H. Practical management of pain, 5th edn. St. Louis: Mosby, 2014
   Google Scholar
• Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet 2004;43:879-923
   PubMed Web of Science ®Google Scholar
• Lassen D, Damkier P, Brosen K. The pharmacogenetics of tramadol. Clin Pharmacokinet 2015;54:825-36
   PubMed Web of Science ®Google Scholar
• Desmeules J, Piguet V, Collart L, Dayer P. Contribution of monoaminergic modulation to the analgesic effect of tramadol. Br J Clin Pharmacol 1996;41:7-12
   PubMed Web of Science ®Google Scholar
• Kirchheiner J, Keulen JTHA, Bauer S, et al. Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol. J Clin Psychopharmacol 2008;28:78-83
   PubMed Web of Science ®Google Scholar
• Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Clin Pharmacokinet 2009;48:689-723
   PubMed Web of Science ®Google Scholar
• Jorge LF, Eichelbaum M, Griese EU, et al. Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: role of selection versus drift in world populations. Pharmacogenetics 1999;9:217-28
   PubMedGoogle Scholar
• Allegaert K, Holford N, Anderson BJ, et al. Tramadol and o-desmethyl tramadol clearance maturation and disposition in humans: a pooled pharmacokinetic study. Clin Pharmacokinet 2015;54:167-78
   PubMed Web of Science ®Google Scholar
• Tramadol for the management of pain in adult patients: a review of the clinical effectiveness. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2015. Available at: https://cadth.ca/tramadol-management-pain-adult-review-clinical-effectiveness
   Google Scholar
• Whittle Sl, Richards Bl, Husni E, et al. Opioid therapy for treating rheumatoid arthritis pain. The Cochrane Library 2011;11:CD003113
   Google Scholar
• Cepeda MS, Camargo F, Zea C, et al. Tramadol for osteoarthritis. The Cochrane Library 2006;3:CD005522
   Google Scholar
• Leppert W, Luczak J. The role of tramadol in cancer pain treatment – a review. Support Care Cancer 2005;13:5-17
   PubMed Web of Science ®Google Scholar
• Scott LJ, Perry CM. Tramadol: a review of its use in perioperative pain. Drugs 2000;60:139-76
   PubMed Web of Science ®Google Scholar
• Duhmke RM, Cornblath DD, Hollingshead JR. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2006;3:CD003726
   Google Scholar
• Chaparro LE, Furlan AD, Desphande A, et al. Opioids compared with placebo or other treatments for chronic low back pain: an update of the Cochrane review. Spine 2014;39:556-63
   PubMed Web of Science ®Google Scholar
• Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010;17:1113-e88
   PubMed Web of Science ®Google Scholar
• Chou R, Qaseem A, Snow V, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007;147:478-91
   PubMed Web of Science ®Google Scholar
• Schnitzer TJ. Update of ACR guidelines for osteoarthritis: role of the coxibs. J Pain Symptom Manage 2002;23:S24-S30
   PubMed Web of Science ®Google Scholar
• National Opioid Use Guide Guideline Group. Canadian guideline for safe and effective use of opioids for chronic non-cancer pain. Available at: http://nationalpaincenter.mcmaster.ca/opioid/2010
   Google Scholar
• Bamigbade TA, Langford RM. The clinical use of tramadol hydrocloride. Pain Rev 1998;5:155-82
   Web of Science ®Google Scholar
• Mildh LH, Leino KA, Kirvela OA. Effects of tramadol and meperidine on respiration, plasma catecholamine concentrations and haemodynamics. J Clin Anesth 1999;11:310-16
   PubMed Web of Science ®Google Scholar
• Oliveira Martins R, Castello-Branco N, de Barros JL, Weber SAT. Risk factors for respiratory complications after adenotonsillectomy in children with obstructive sleep apnea. J Bras Pneumol 2015;41:238-45
   PubMed Web of Science ®Google Scholar
• Haslam C, Nurmikko T. Pharmacological treatment of neuropathic pain in older persons. Clin Interv Aging 2008;3:111-20
   PubMed Web of Science ®Google Scholar
• Attal N, Cruccu G, Haanpaa M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Europ J Neurol 2006;13:1153-69
   PubMed Web of Science ®Google Scholar
• Rosenthal N, Silverfield J, Wu S, et al. Tramadol/acetaminophen combination tablets for the treatment of pain associated with osteoarthritis flare in an elderly patient population. J Am Geriat Soc 2004;52:374-80
   PubMed Web of Science ®Google Scholar
• Cavalieri TA. Managing pain in geriatric patients. J Am Osteopathic Assoc 2007;107:10-16
   Google Scholar
• Hassanian Moghaddam H, Farnaghi F, Rahimi M. Tramadol overdose and apnea in hospitalized children, a review of 20 cases. Res Pharm Sci 2015;10:544-52
   PubMed Web of Science ®Google Scholar
• Stassinos GL, Gonzales L, Klein Schwartz W. Characterizing the toxicity and dose–effect profile of tramadol ingestions in children. Clin Toxicol (Phila PA) 2017;53:707
   Web of Science ®Google Scholar
• Walton Betancourth SB, Pal C. Tramadol intoxication: an emerging entity in pediatrics? Arch Dis Child 2014;99(Suppl1):A13
   Google Scholar
• Lara-Solares A, Aguayo Zamora C, Amescua García C, et al. Latin-American guidelines for opioid use in chronic nononcologic pain. Pain Manag 2017;7:207-215
   PubMed Web of Science ®Google Scholar
• Lara-Solares A, Ahumada Olea M, Basantes Pinos AL. Latin-American guidelines for cancer pain management. Pain Manag 2017. doi: 10.2217/pmt-2017-0006. [Epub ahead of print]
   Google Scholar
• Mamdani M, Juurlink DN, Kopp A, et al. Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study. BMJ 2004;328:1415
   PubMed Web of Science ®Google Scholar
• Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999;106:13-24S
   PubMedGoogle Scholar
• Harbin M, Turgeon R, Kolber M, et al. Cardiovascular safety of NSAIDs. Can Fam Physician 2014;60:e166
   PubMed Web of Science ®Google Scholar
• Hsu SK, Yeh CC, Lin CJ, et al. An open label trial of the effects and safety profile of extend-release tramadol in the management of chronic pain. Acta Anaesthesiol Taiwan 2012;50:101-5
   PubMedGoogle Scholar
• NICE 2015. Non-steroidal anti-inflammatory drugs. Key therapeutic topic. Available at: http://www.nice.org.uk/guidance/ktt13
   Google Scholar
• Petrone D, Kamin M, Olson W. Slowing the titration rate of tramadol HCL reduces the incidence of discontinuation due to nausea and/or vomiting. A double-blind randomized trial. J Clinic Pharm Therapeut 1999;24:115-23
   PubMed Web of Science ®Google Scholar
• Houmes RJ, Voets MA, Verkaaik A, et al. Efficacy and safety of tramadol versus morphine for moderate and severe postoperative pain with special regards to respiratory depression. Anesth Analg 1992;74:510-14
   PubMed Web of Science ®Google Scholar
• Vickers MD, Paravicini D. Comparison of tramadol with morphine for post-operative pain following abdominal surgery. Eur J Anaesthesiol 1995;12:265-71
   PubMed Web of Science ®Google Scholar
• Langford RM, Bakhshi KN, Moylan S, et al. Hypoxaemia after lower abdominal surgery: comparison of tramadol and morphine. Acute Pain 1998;1:7-12
   Google Scholar
• Tarkkila P, Tuominen M, Lindgren L. Comparison of respiratory effects of tramadol and oxycodone. J Clin Anesth 1997;9:582-5
   PubMed Web of Science ®Google Scholar
• Tarkkila P, Tuominen M, Lindgren L. Comparison of respiratory effects of tramadol and pethidine. Europ J Anaesthesiol 1998;15:64-8
   PubMed Web of Science ®Google Scholar
• Bösenberg AT, Ratcliffe S. The respiratory effects of tramadol in children under halothane an anaesthesia. Anaesthesia 1998;53:960-4
   PubMed Web of Science ®Google Scholar
• Schäffer J, Piepenbrock S, Kretz FJ. Nalbuphine and tramadol for the control of postoperative pain in children. Anaesthetist 1986;35:408-13
   PubMed Web of Science ®Google Scholar
• Sacerdote P. Opioid-induced immunosuppression. Curr Opin Support Palliat Care 2008;2:14-18
   PubMedGoogle Scholar
• Sacerdote P, Bianchi M, Manfredi B, et al. Effects of tramadol on immune responses and nociceptive thresholds in mice. Pain 1997;72:325-30
   PubMed Web of Science ®Google Scholar
• Van Amsterdam J, van der Brink W. The misuse of prescription opioids: a threat for Europe? Curr Drug Abuse Rev 2015;8:3-14
   PubMedGoogle Scholar
• Adams Eh, Breiner S, Cicero TJ, et al. A comparison of the abuse ability liability of tramadol, NSAIDs and hydrocodone in patients with chronic pain. J Pain Symptom Manage 2006;31:465-76
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Inciardi JA, Adams EH, et al. Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system 1994–2004. Pharmacoepidimiol Drug Saf 2005;14:851-9
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Dart RC, Inciardi JA, et al. The development of a comprehensive risk management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance. Pain Med 2007;8:157-70
   PubMed Web of Science ®Google Scholar
• Raffa RB. Basic pharmacology relevant to drug abuse assessment: tramadol as example. J Clin Pharm Ther 2008;33:101-8
   PubMed Web of Science ®Google Scholar
• Epstein DH, Preston KL, Jasinski DR. Abuse liability, behavioural pharmacology and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol. Biol Psychol 2006;73:90-9
   PubMed Web of Science ®Google Scholar
• Knisely JS, Campbell ED, Dawson KS, et al. Tramadol post-marketing surveillance in health care professionals. Drug and Alcohol Dependence 2002;68:15-22
   PubMed Web of Science ®Google Scholar
• Schneider MF, Bailey JE, Cicero TJ, et al. Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007. Pharmacoepidemiol Drug Saf 2009;18:778-90
   PubMed Web of Science ®Google Scholar
• WHO Expert Committee on Drug Dependence (WHO ECDD) 2014. Available at: http://www.who.int/medicines/areas/quality_safety/36thecddmeet/en/index5.html
   Google Scholar
• National Opioid Use Guideline Group (NOUGG) of Canada. Available at: http://nationalpaincentre.mcmaster.ca/opioid/
   Google Scholar